Showing results (2261-2270 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|January 17, 2025
Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 studyKatia Alves, Karen Kotloff, R Scott McClelland, et al.
The Lancet. Infectious Diseases|January 11, 2025
The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case-control and bias indicator studyRobin C Nesbitt, Vincent Kinya Asilaza, Catia Alvarez, et al.
The Lancet. Infectious Diseases|January 12, 2025
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trialEl-Hadji Konko Ciré Ba, Michelle E Roh, Abdoulaye Diallo, et al.
The Lancet. Infectious Diseases|March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trialÁlvaro H Borges, Marisa Russell, Dereck Tait, et al.
The Lancet. Infectious Diseases|April 6, 2025
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapiesPer Ljungman, Sophie Alain, Roy F Chemaly, et al.
The Lancet. Infectious Diseases|April 5, 2025
Efficacy and safety of individualised versus standard 10-day antibiotic treatment in children with febrile urinary tract infection (INDI-UTI): a pragmatic, open-label, multicentre, randomised, controlled, non-inferiority trial in DenmarkNaqash Javaid Sethi, Emma Louise Malchau Carlsen, Abdullah Tabassum, et al.
The Lancet. Infectious Diseases|March 6, 2025
Antimicrobials in serious illness and end-of-life care: lifting the veil of silenceWilliam E Rosa, Shila Pandey, Renee Wisniewski, et al.
The Lancet. Infectious Diseases|December 21, 2024
Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection studyBenoit Bestgen, Sam Jones, Vandana Thathy, et al.
The Lancet. Infectious Diseases|November 10, 2024
Research and product development for Crimean-Congo haemorrhagic fever: priorities for 2024-30Amanda E Semper, Janie Olver, Jenny Warner, et al.
The Lancet. Infectious Diseases|November 3, 2024
Serotype-specific epidemiological patterns of inapparent versus symptomatic primary dengue virus infections: a 17-year cohort study in NicaraguaSandra Bos, José Victor Zambrana, Elias Duarte, et al.
Pageof 270